Prophylactic fluconazole does not improve outcome in patients with purulent and fecal peritonitis due to lower gastrointestinal perforation

American Surgeon

Volumn 76, Issue 2, 2010, Pages 197-202

  Khoury, Wisam ^a   Szold, Oded ^a   Soffer, Dror ^a   Kariv, Yehuda ^a   Wasserlauf, Ruth ^a   Klausner, Joseph M ^a   Ogorek, Daniel ^a   Weinbroum, Avi A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTRIAXONE; CEPHALOSPORIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL ABSCESS; ADULT; AGED; ANTIBIOTIC RESISTANCE; APACHE; APPENDIX PERFORATION; ARTICLE; BACTEREMIA; CANDIDIASIS; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; FECAL PERITONITIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTESTINE PERFORATION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PERITONEAL FLUID; PERITONITIS; PNEUMONIA; POSTOPERATIVE INFECTION; PROPHYLAXIS; PURULENT PERITONITIS; TREATMENT OUTCOME; WOUND INFECTION;

AGED; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTESTINAL PERFORATION; ISRAEL; LENGTH OF STAY; MALE; PERITONITIS; RETROSPECTIVE STUDIES; SUPPURATION; SURGICAL WOUND INFECTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77949513729     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beck-Sague CM, Jarvis WR. National Nosocomial Infections Surveillance System: secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247-51.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
3. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intra-abdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996;23:486-94.
4. Roehrborn A, Thomas L, Potreck O, et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001;33:1513-9.
5. Calandra T, Bille J, Schneider R, et al. Clinical significance of candida isolated from peritoneum in surgical patients. Lancet 1989;2:1437-40.
6. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of candida in intraperitoneal infections. Surgery 1980;88:524-30.
7. Edwards JE, Bodey GP, Bowden RA, et al. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 1997;25:43-59, Review.
8. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-78.
9. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-72.
10. Dupont H, Bourichon A, Paugam-Burtz C, et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003;31:752-7.
11. Salminen S, Isolauri S, Onnela T. Gut flora in normal and disordered states. Chemotherapy 1995;41(suppl 1): 5-15.
12. Garrelts JC, Schroeder TR, Harrison PB. Impact of fluconazole administration on outcomes in critically ill patients. Ann Pharmacother 2004;38:1588-92.
13. Rantala A, Lehtonen OP, Kuttila K, et al. Diagnostic factors for postoperative candidosis in abdominal surgery. Ann Chir Gynaecol 1991;80:323-8.
14. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996;171:374-82, Review.
15. Flanagan PG, Barnes RA. Fungal infection in the intensive care unit. J Hosp Infect 1998;38:163-77, Review.
16. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001;233:542-8.
17. Dupont H, Paugam-Burtz C, Muller-Serieys C, et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 2002;137:1341-6, discussion 1347.
18. Sandven P, Qvist H, Skovlund E, Giercksky KE. The NORGAS group and the Norwegian yeast study group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002;30:541-7.
19. Rocco TR, Reinert SE, Simms HH. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. Arch Surg 2000;135:160-5.
20. Kappe R, Streitzig S, Bohrer H. Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care. Dtsch Med Wochenschr 2001;126:905-8, German.
21. Safran DB, Dawson E. The effect of empiric and prophylactic treatment with fluconazole on yeast isolates in a surgical trauma intensive care unit. Arch Surg 1997;132:1184-8, discussion 1188-9.
22. Shan YS, Sy ED,Wang ST, et al. Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. World J Surg 2006;30:119-26.